Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 p.m. ET
Zomedica (NYSE American:ZOM), a veterinary health company specializing in point-of-care diagnostic and therapeutic products for equine and companion animals, has scheduled its Q3 2024 earnings conference call for November 7, 2024, at 4:30 p.m. ET. The call will cover operational and financial highlights for the quarter ended September 30, 2024, followed by a Q&A session. Participants can join via phone (+1-800-717-1738 U.S. Toll-Free or +1-646-307-1865 International) or webcast. A replay will be available until November 21, 2024.
Zomedica (NYSE American:ZOM), un'azienda sanitaria veterinaria specializzata in prodotti diagnostici e terapeutici point-of-care per animali equini e da compagnia, ha programmato la sua conferenza telefonica sugli utili del Q3 2024 per il 7 novembre 2024, alle 16:30 ET. La chiamata discuterà i punti salienti operativi e finanziari del trimestre conclusosi il 30 settembre 2024, seguita da una sessione di domande e risposte. I partecipanti possono unirsi tramite telefono (+1-800-717-1738 numero verde USA o +1-646-307-1865 internazionale) oppure tramite webcast. Una registrazione sarà disponibile fino al 21 novembre 2024.
Zomedica (NYSE American:ZOM), una compañía de salud veterinaria especializada en productos diagnósticos y terapéuticos point-of-care para animales equinos y de compañía, ha programado su llamada de conferencia sobre ganancias del Q3 2024 para el 7 de noviembre de 2024, a las 4:30 p.m. ET. La llamada cubrirá los aspectos destacados operativos y financieros del trimestre que finalizó el 30 de septiembre de 2024, seguida de una sesión de preguntas y respuestas. Los participantes pueden unirse por teléfono (+1-800-717-1738 número gratuito en EE.UU. o +1-646-307-1865 internacional) o a través de la transmisión en vivo. Se dispondrá de una grabación hasta el 21 de noviembre de 2024.
조메디카 (NYSE American:ZOM)는 말과 반려동물을 위한 포인트 오브 케어 진단 및 치료 제품을 전문으로 하는 수의료 회사로, 2024년 3분기 실적 컨퍼런스 콜을 2024년 11월 7일 오후 4시 30분 ET에 예정하고 있습니다. 이 통화에서는 2024년 9월 30일로 종료된 분기의 운영 및 재무 하이라이트가 다뤄지며, 질문과 답변 세션이 이어집니다. 참가자는 전화(+1-800-717-1738 미국 무료 또는 +1-646-307-1865 국제) 또는 웹캐스트를 통해 참여할 수 있습니다. 녹음은 2024년 11월 21일까지 청취 가능합니다.
Zomedica (NYSE American:ZOM), une entreprise de santé vétérinaire spécialisée dans les produits de diagnostic et de traitement de point-of-care pour les équidés et les animaux de compagnie, a programmé sa conférence de résultats du T3 2024 pour le 7 novembre 2024 à 16h30 ET. L'appel couvrira les points saillants opérationnels et financiers pour le trimestre se terminant le 30 septembre 2024, suivi d'une session de questions-réponses. Les participants peuvent rejoindre par téléphone (+1-800-717-1738 numéro gratuit aux États-Unis ou +1-646-307-1865 international) ou par webdiffusion. Un enregistrement sera disponible jusqu'au 21 novembre 2024.
Zomedica (NYSE American:ZOM), ein Unternehmen der tiermedizinischen Gesundheitsbranche, das sich auf diagnostische und therapeutische Produkte für den Point-of-Care bei Pferden und Haustieren spezialisiert hat, hat seine Q3 2024 Ergebnis-Konferenzschaltung für den 7. November 2024 um 16:30 Uhr ET angesetzt. Der Anruf behandelt die operativen und finanziellen Höhepunkte des zum 30. September 2024 endenden Quartals, gefolgt von einer Frage- und Antwortsitzung. Die Teilnehmer können telefonisch (+1-800-717-1738 gebührenfrei in den USA oder +1-646-307-1865 international) oder per Webcast teilnehmen. Eine Wiederholung wird bis zum 21. November 2024 verfügbar sein.
- None.
- None.
ANN ARBOR, MI / ACCESSWIRE / October 23, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, will host a conference call and audio-only webcast on Thursday, November 7, 2024, at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its thirdquarter ended September 30, 2024. A question-and-answer session will follow management's prepared remarks.
Event: Zomedica Corp. Q3 2024 Financial Results Conference Call
Date: Thursday, November 7, 2024
Time: 4:30 p.m. Eastern Time
Live Call: +1-800-717-1738 (U.S. Toll-Free) or +1-646-307-1865 (International)
Webcast: LINK
For interested individuals unable to join the conference call, a dial-in replay of the call will be available until Thursday, November 21, 2024 at 11:59 PM ET and can be accessed by dialing +1-844-512-2921 (U.S. Toll-Free) or +1-412-317-6671 (International) and entering replay pin number: 1120247
About Zomedica
Zomedica is a leading equine and companion animal healthcare company dedicated to improving animal health by providing veterinarians innovative therapeutic and diagnostic solutions. Our gold standard PulseVet® shock wave system, which accelerates healing in musculoskeletal conditions, has transformed veterinary therapeutics. Our suite of products also includes the Assisi® Loop line of therapeutic devices and the TRUFORMA® diagnostic platform, the TRUVIEW™ digital cytology system, and the VetGuardian® no-touch monitoring system, all designed to empower veterinarians to provide top-tier care. In the aggregate, their total addressable market in the U.S. exceeds
Follow Zomedica
Email Alerts: http://investors.zomedica.com
LinkedIn: https://www.linkedin.com/company/zomedica
X (formerly Twitter): https://x.com/zomedica
Facebook: https://m.facebook.com/zomedica
Instagram: https://www.instagram.com/zomedica_inc
Investor Relations Contact:
Zomedica Investor Relations
investors@zomedica.com
1-734-369-2555
SOURCE: Zomedica Corp.
View the original press release on accesswire.com
FAQ
When will Zomedica (ZOM) report Q3 2024 earnings?
How can I listen to Zomedica's (ZOM) Q3 2024 earnings call?